A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05357989 |
Recruitment Status :
Completed
First Posted : May 3, 2022
Last Update Posted : February 8, 2024
|
Sponsor:
Annovis Bio Inc.
Collaborator:
TFS Trial Form Support
Information provided by (Responsible Party):
Annovis Bio Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | December 4, 2023 |
Actual Study Completion Date : | December 4, 2023 |